Ftse Mib
38.421,05
0,45%
DAX
22.287,56
-0,24%
S&P 500
6.013,13
-1,71%
NASDAQ
19.524,01
-2,20%
Bitcoin
96.384,73
-0,19%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ OptiNose Inc (OPTN) OptiNose Inc (OPTN) Notizie

OptiNose Inc

OPTN
5,77
-0,23 (-3,83%)
21 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
07/2/202517:58EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
15/1/202513:52EDGAR2Form 8-K - Current report
15/1/202513:00GLOBEOptinose Announces Preliminary Unaudited Fourth Quarter 2024..
30/12/202422:32EDGAR2Form 8-K - Current report
26/12/202413:00GLOBEOptinose Announces 1-for-15 Reverse Stock Split
23/12/202415:08EDGAR2Form 8-K - Current report
18/12/202422:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202422:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/12/202415:10EDGAR2Form 144 - Report of proposed sale of securities
17/12/202415:05EDGAR2Form 144 - Report of proposed sale of securities
12/12/202416:04EDGAR2Form DEF 14A - Other definitive proxy statements
02/12/202422:05EDGAR2Form PRE 14A - Other preliminary proxy statements
02/12/202421:53GLOBEOptinose to Present at the Piper Sandler 36th Annual..
27/11/202422:16EDGAR2Form DEF 14A - Other definitive proxy statements
12/11/202414:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202413:24EDGAR2Form 8-K - Current report
12/11/202413:00GLOBEOptinose Reports Third Quarter 2024 Financial Results and..
05/11/202422:30GLOBEOptinose Announces Reporting Date for Third Quarter 2024..
18/10/202420:52EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
16/10/202423:01EDGAR2Form 8-K - Current report
16/10/202422:05GLOBEOptinose Announces Inducement Grants Under Nasdaq Listing..
08/10/202400:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/10/202400:39EDGAR2Form 3 - Initial statement of beneficial ownership of..
07/10/202422:59GLOBEOptinose Appoints Terry Kohler as Chief Financial Officer
25/9/202422:33EDGAR2Form 8-K - Current report
18/9/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202422:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/9/202402:37EDGAR2Form 144 - Report of proposed sale of securities
17/9/202402:36EDGAR2Form 144 - Report of proposed sale of securities
05/9/202415:00GLOBENew Peer-Reviewed Data Highlight the Benefits of XHANCE in..
26/8/202415:00GLOBEOptinose to Present at the H.C. Wainwright 26th Annual..
08/8/202413:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202413:13EDGAR2Form 8-K - Current report
08/8/202413:00GLOBEOptinose Reports Second Quarter 2024 Financial Results and..
02/8/202414:30GLOBEOptinose Announces Reporting Date for Second Quarter 2024..
18/7/202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/7/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/7/202422:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/7/202422:47EDGAR2Form 144 - Report of proposed sale of securities
15/7/202422:45EDGAR2Form 144 - Report of proposed sale of securities
15/7/202422:44EDGAR2Form 144 - Report of proposed sale of securities
27/6/202413:00GLOBEExpanded Access to XHANCE with Addition to National..
18/6/202423:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/6/202423:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202422:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:33EDGAR2Form 8-K - Current report
29/5/202421:32EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
Apertura: 6,05 Min: 5,71 Max: 6,185
Chiusura: 6,00

La tua Cronologia

NASDAQ
OPTN
OptiNose
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci